Cargando…

Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.

We have investigated the relationships between nitrosourea structure and physicochemical properties and the ability of misonidazole (MISO) to potentiate nitrosourea cytotoxicity in an in vitro model system. EMT-6/Ro tumour cells were exposed in suspension to each of 9 different nitrosourea anti-tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulcahy, R. T., Dembs, N. L., Ublacker, G. A.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1984
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976738/ https://www.ncbi.nlm.nih.gov/pubmed/6704305

Ejemplares similares

Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
por: Wheeler, K. T., et al.
Publicado: (1984)

Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
por: Mulcahy, R. T., et al.
Publicado: (1982)

Bleomycin and misonidazole cytotoxicity.
por: Korbelik, M., et al.
Publicado: (1985)

Chemopotentiation of CCNU metabolites by misonidazole.
por: Mulcahy, R. T.
Publicado: (1985)

Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
por: Hirst, D. G., et al.
Publicado: (1982)

Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
por: Roizin-Towle, L. A., et al.
Publicado: (1981)

In vitro metabolism of misonidazole.
por: Josephy, P. D., et al.
Publicado: (1981)

Cytotoxicity of metronidazole (Flagyl) and misonidazole (Ro-07-0582): enhancement by lactate.
por: Mahood, J. S., et al.
Publicado: (1981)

Split dose cytotoxic experiments with misonidazole.
por: Stratford, I. J.
Publicado: (1978)

Combination studies with misonidazole and a cis-platinum complex: cytotoxicity and radiosensitization in vitro.
por: Stratford, I. J., et al.
Publicado: (1980)

Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole.
por: Miller, R. C., et al.
Publicado: (1978)

The penetration of misonidazole into spontaneous canine tumours.
por: White, R. A., et al.
Publicado: (1979)

Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
por: Astor, M., et al.
Publicado: (1979)

In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole.
por: Siemann, D. W., et al.
Publicado: (1984)

Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.
por: Taylor, Y. C., et al.
Publicado: (1980)

Oxygen dependence for chemosensitization by misonidazole.
por: Roizin-Towle, L., et al.
Publicado: (1986)

Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.
por: Pedersen, J. E., et al.
Publicado: (1979)

Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
por: Law, M. P., et al.
Publicado: (1981)

Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
por: Murray, D., et al.
Publicado: (1983)

Optimizing the interval between administration of misonidazole and irradiation: an in vitro study.
por: Hall, E. J., et al.
Publicado: (1982)

Is tumour radiosensitization by misonidazole a general phenomenon?
por: Denekamp, J., et al.
Publicado: (1980)

Factors influencing the chemosensitization of melphalan by misonidazole.
por: Randhawa, V. S., et al.
Publicado: (1985)

The role of dexamethasone in the modification of misonidazole pharmacokinetics.
por: Jones, D. H., et al.
Publicado: (1983)

Microscopic distribution of misonidazole in mouse tissues.
por: Cobb, L. M., et al.
Publicado: (1989)

Does misonidazole enhance radiation injury to the central nervous system?
por: Field, S. B., et al.
Publicado: (1981)

Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.
por: Stephens, T. C., et al.
Publicado: (1981)

Modulation of the hypoxic toxicity and binding of misonidazole by glucose.
por: Ling, L. L., et al.
Publicado: (1986)

The penetration of misonidazole into a mature structural cartilage.
por: Langler, A. J., et al.
Publicado: (1982)

The quantitative response of human tumours to radiation and misonidazole.
por: Ash, D. V., et al.
Publicado: (1979)

Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
por: McNally, N. J., et al.
Publicado: (1983)

Distribution of misonidazole in human tumours and normal tissues.
por: Ash, D. V., et al.
Publicado: (1979)

Misonidazole enhancement of acute and late radiation injury to the rat spinal cord.
por: Yuhas, J. M.
Publicado: (1979)

Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.
por: Smith, E., et al.
Publicado: (1982)

Dependence of misonidazole binding on factors associated with hypoxic metabolism.
por: Ling, L. L., et al.
Publicado: (1987)

Studies with bleomycin and misonidazole on aerated and hypoxic cells.
por: Roizin-Towle, L., et al.
Publicado: (1978)

Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
por: Durand, R. E., et al.
Publicado: (1987)

Peripheral electrophysiological parameters in mice treated with misonidazole.
por: Von Burg, R., et al.
Publicado: (1979)

Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
por: Horsman, M. R., et al.
Publicado: (1984)

Influence of misonidazole on the incidence of radiation-induced intestinal tumours in mice.
por: Rostom, A. Y., et al.
Publicado: (1978)

Interactions between misonidazole and hyperthermia in EMT6 spheroids.
por: Morgan, J. E., et al.
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_61944rimmkcc493c9othuithc2